- Home
- SKYE vs MDIA Comparison
SKYE vs MDIA Comparison
Compare SKYE & MDIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- MDIA
- Stock Information
- Founded
- SKYE 2012
- MDIA 2019
- Country
- SKYE United States
- MDIA United States
- Employees
- SKYE N/A
- MDIA N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- MDIA Broadcasting
- Sector
- SKYE Health Care
- MDIA Consumer Discretionary
- Exchange
- SKYE Nasdaq
- MDIA Nasdaq
- Market Cap
- SKYE 94.0M
- MDIA 61.4M
- IPO Year
- SKYE N/A
- MDIA N/A
- Fundamental
- Price
- SKYE $2.73
- MDIA $1.03
- Analyst Decision
- SKYE Buy
- MDIA
- Analyst Count
- SKYE 6
- MDIA 0
- Target Price
- SKYE $18.67
- MDIA N/A
- AVG Volume (30 Days)
- SKYE 167.7K
- MDIA 308.4K
- Earning Date
- SKYE 02-09-2025
- MDIA 11-14-2024
- Dividend Yield
- SKYE N/A
- MDIA N/A
- EPS Growth
- SKYE N/A
- MDIA N/A
- EPS
- SKYE N/A
- MDIA N/A
- Revenue
- SKYE N/A
- MDIA $69,296,000.00
- Revenue This Year
- SKYE N/A
- MDIA N/A
- Revenue Next Year
- SKYE N/A
- MDIA N/A
- P/E Ratio
- SKYE N/A
- MDIA N/A
- Revenue Growth
- SKYE N/A
- MDIA 94.96
- 52 Week Low
- SKYE $2.25
- MDIA $0.40
- 52 Week High
- SKYE $19.41
- MDIA $6.86
- Technical
- Relative Strength Index (RSI)
- SKYE 37.40
- MDIA 36.66
- Support Level
- SKYE $2.31
- MDIA $0.92
- Resistance Level
- SKYE $3.04
- MDIA $1.25
- Average True Range (ATR)
- SKYE 0.30
- MDIA 0.12
- MACD
- SKYE 0.07
- MDIA -0.01
- Stochastic Oscillator
- SKYE 44.68
- MDIA 33.33
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales and events including sponsorships and ticket sales, licensing, and syndication.